Bio-Gene Technology Ltd
BGT
Company Profile
Business description
Bio-Gene Technology Ltd is to pursue the development and commercialisation of naturally derived insecticide products. Its insecticide active ingredients are Flavocide, a synthetically produced nature-identical compound, and Qcide, a natural plant-derived oil with high levels of tasmanone. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.
Contact
400 Collins Street
Level 6
MelbourneVIC3000
AUST: +61 390681062
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Undervalued REIT receives offer from PE firm
Our analysts’ view on the value of the unsolicited offer.
stocks
Apple: With launch of foldable iPhone duo things look twice as nice
We’ve raised our fair value estimate of Apple stock.
stocks
What did Morningstar subscribers buy and sell during August?
Earnings season fuels trading activity.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,908.80 | 2.40 | 0.03% |
| CAC 40 | 8,116.76 | 0.00 | 0.00% |
| DAX 40 | 25,361.15 | 215.30 | -0.84% |
| Dow JONES (US) | 52,064.10 | 316.56 | -0.60% |
| FTSE 100 | 10,608.92 | 61.14 | -0.57% |
| HKSE | 24,742.51 | 211.96 | -0.85% |
| NASDAQ | 26,081.72 | 171.62 | -0.65% |
| Nikkei 225 | 63,819.64 | 1,451.31 | -2.22% |
| NZX 50 Index | 13,570.09 | 140.92 | -1.03% |
| S&P 500 | 7,591.70 | 44.66 | -0.58% |
| S&P/ASX 200 | 8,731.10 | 13.20 | 0.15% |
| SSE Composite Index | 3,862.73 | 71.67 | -1.82% |